Skip to content 
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified. more
| Time Frame | BIB | S&P500 |
|---|---|---|
| 1-Week Return | 6.3% | 2.88% |
| 1-Month Return | -6.5% | 2.81% |
| 3-Month Return | 24.45% | 5.03% |
| 6-Month Return | 19.03% | 10.68% |
| 1-Year Return | 105.05% | 21.52% |
| 3-Year Return | 102.11% | 70.6% |
| 5-Year Return | -6.98% | 73.79% |
| 10-Year Return | 103.08% | 253.08% |
| Stock name | Ticker | Weight |
|---|---|---|
 Net Other Assets (Liabilities) | Net.Other.Assets..Liabilities. | 40.82% |
 PROSHARES GENIUS MNY MKT ETF | IQMM | 5.81% |
 AMGEN INC | AMGN | 4.65% |
 VERTEX PHARMACEUTICALS INC | VRTX | 4.23% |
 GILEAD SCIENCES INC | GILD | 3.78% |
 REGENERON PHARMACEUTICALS | REGN | 2.94% |
 REVOLUTION MEDICINES INC | RVMD | 1.59% |
 BIOGEN INC | BIIB | 1.12% |
 ALNYLAM PHARMACEUTICALS INC | ALNY | 1.06% |
 ILLUMINA INC | ILMN | 1.03% |
 INSMED INC | INSM | 1.03% |
 ROIVANT SCIENCES LTD | ROIV | 0.95% |
 ROYALTY PHARMA PLC- CL A | RPRX | 0.92% |
 INCYTE CORP | INCY | 0.88% |
 ARGENX SE - ADR | ARGX | 0.87% |
 MODERNA INC | MRNA | 0.85% |
 UNITED THERAPEUTICS CORP | UTHR | 0.83% |
 GUARDANT HEALTH INC | GH | 0.81% |
 VIATRIS INC | VTRS | 0.7% |
 MEDPACE HOLDINGS INC | MEDP | 0.61% |
 BRIDGEBIO PHARMA INC | BBIO | 0.6% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 0.6% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 0.59% |
 ASCENDIS PHARMA A/S | ASND | 0.57% |
 EXELIXIS INC | EXEL | 0.49% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.45% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 0.45% |
 HALOZYME THERAPEUTICS INC | HALO | 0.44% |
 MADRIGAL PHARMACEUTICALS INC | MDGL | 0.43% |
 BEONE MEDICINES LTD-ADR | ONC | 0.42% |
 AXSOME THERAPEUTICS INC | AXSM | 0.4% |
 BIONTECH SE-ADR | BNTX | 0.4% |
 SUMMIT THERAPEUTICS INC | SMMT | 0.39% |
 CYTOKINETICS INC | CYTK | 0.38% |
 SANOFI-ADR | SNY | 0.37% |
 PRAXIS PRECISION MEDICINES I | PRAX | 0.37% |
 KRYSTAL BIOTECH INC | KRYS | 0.35% |
 PROTAGONIST THERAPEUTICS INC | PTGX | 0.34% |
 IONIS PHARMACEUTICALS INC | IONS | 0.34% |
 SPYRE THERAPEUTICS INC | SYRE | 0.33% |
 TEMPUS AI INC-CL A | TEM | 0.33% |
 CRINETICS PHARMACEUTICALS IN | CRNX | 0.32% |
 KYMERA THERAPEUTICS INC | KYMR | 0.32% |
 VAXCYTE INC | PCVX | 0.3% |
 APOGEE THERAPEUTICS INC | APGE | 0.3% |
 IMMUNOVANT INC | IMVT | 0.3% |
 ALKERMES PLC | ALKS | 0.3% |
 IMMUNITYBIO INC | IBRX | 0.29% |
 RHYTHM PHARMACEUTICALS INC | RYTM | 0.29% |
 ABIVAX SA-ADR | ABVX | 0.28% |
 COGENT BIOSCIENCES INC | COGT | 0.26% |
 TWIST BIOSCIENCE CORP | TWST | 0.26% |
 CG ONCOLOGY INC | CGON | 0.24% |
 CARIS LIFE SCIENCES INC | CAI | 0.23% |
 SCHOLAR ROCK HOLDING CORP | SRRK | 0.23% |
 MIRUM PHARMACEUTICALS INC | MIRM | 0.22% |
 XENON PHARMACEUTICALS INC | XENE | 0.22% |
 10X GENOMICS INC-CLASS A | TXG | 0.22% |
 PTC THERAPEUTICS INC | PTCT | 0.22% |
 ORUKA THERAPEUTICS INC | ORKA | 0.22% |
 LIGAND PHARMACEUTICALS | LGND | 0.21% |
 AMNEAL PHARMACEUTICALS INC | AMRX | 0.21% |
 ERASCA INC | ERAS | 0.21% |
 TRAVERE THERAPEUTICS INC | TVTX | 0.21% |
 CRISPR THERAPEUTICS AG | CRSP | 0.19% |
 DEFINIUM THERAPEUTICS INC | DFTX | 0.18% |
 ACADIA PHARMACEUTICALS INC | ACAD | 0.18% |
 INDIVIOR PHARMACEUTICALS INC | INDV | 0.17% |
 EDGEWISE THERAPEUTICS INC | EWTX | 0.17% |
 DYNE THERAPEUTICS INC | DYN | 0.16% |
 RELAY THERAPEUTICS INC | RLAY | 0.15% |
 STRUCTURE THERAPEUTICS INC | GPCR | 0.15% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.15% |
 DENALI THERAPEUTICS INC | DNLI | 0.14% |
 TANGO THERAPEUTICS INC | TNGX | 0.14% |
 VERACYTE INC | VCYT | 0.14% |
 ENLIVEN THERAPEUTICS INC | ELVN | 0.13% |
 KINIKSA PHARMACEUTICALS INTE | KNSA | 0.13% |
 ALUMIS INC | ALMS | 0.12% |
 NEWAMSTERDAM PHARMA CO NV | NEWAMSTERDAM.PHARMA.CO.NV | 0.12% |
 IDEAYA BIOSCIENCES INC | IDYA | 0.12% |
 MBX BIOSCIENCES INC | MBX | 0.12% |
 ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.12% |
 GRAIL INC | GRAL | 0.11% |
 DISC MEDICINE INC | IRON | 0.11% |
 UNIQURE NV | QURE | 0.11% |
 KODIAK SCIENCES INC | KOD | 0.1% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.1% |
 BEAM THERAPEUTICS INC | BEAM | 0.1% |
 TARSUS PHARMACEUTICALS INC | TARS | 0.1% |
 SUPERNUS PHARMACEUTICALS INC | SUPN | 0.1% |
 ATAIBECKLEY INC | ATAI | 0.1% |
 NURIX THERAPEUTICS INC | NRIX | 0.1% |
 TREVI THERAPEUTICS INC | TRVI | 0.1% |
 PRECIGEN INC | PGEN | 0.09% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.09% |
 AMYLYX PHARMACEUTICALS INC | AMLX | 0.09% |
 PHARVARIS NV | PHVS | 0.09% |
 BIOCRYST PHARMACEUTICALS INC | BCRX | 0.09% |
 GENMAB A/S -SP ADR | GMAB | 0.09% |
 VERA THERAPEUTICS INC | VERA | 0.09% |
 SIONNA THERAPEUTICS INC | SION | 0.08% |
 VERICEL CORP | VCEL | 0.08% |
 ADMA BIOLOGICS INC | ADMA | 0.08% |
 UROGEN PHARMA LTD | URGN | 0.08% |
 MINERALYS THERAPEUTICS INC | MLYS | 0.08% |
 HARMONY BIOSCIENCES HOLDINGS | HRMY | 0.08% |
 RAPPORT THERAPEUTICS INC | RAPP | 0.08% |
 ABCELLERA BIOLOGICS INC | ABCL | 0.08% |
 GH RESEARCH PLC | GHRS | 0.08% |
 ZENAS BIOPHARMA INC | ZBIO | 0.07% |
 STOKE THERAPEUTICS INC | STOK | 0.07% |
 AURINIA PHARMACEUTICALS INC | AUPH | 0.07% |
 OCULAR THERAPEUTIX INC | OCUL | 0.07% |
 AGIOS PHARMACEUTICALS INC | AGIO | 0.07% |
 NOVOCURE LTD | NVCR | 0.07% |
 TAYSHA GENE THERAPIES INC | TSHA | 0.07% |
 BICARA THERAPEUTICS INC | BCAX | 0.07% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.07% |
 COMPASS PATHWAYS PLC | CMPS | 0.07% |
 ANI PHARMACEUTICALS INC | ANIP | 0.06% |
 SAREPTA THERAPEUTICS INC | SRPT | 0.06% |
 LEGEND BIOTECH CORP-ADR | LEGN | 0.06% |
 SEPTERNA INC | SEPN | 0.06% |
 FORTREA HOLDINGS INC | FTRE | 0.06% |
 ZYMEWORKS INC | ZYME | 0.06% |
 RECURSION PHARMACEUTICALS-A | RXRX | 0.06% |
 INTELLIA THERAPEUTICS INC | NTLA | 0.06% |
 ANAPTYSBIO INC | ANAB | 0.06% |
 MAZE THERAPEUTICS INC | MAZE | 0.06% |
 FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.06% |
 TYRA BIOSCIENCES INC | TYRA | 0.06% |
 XENCOR INC | XNCR | 0.06% |
 IMMUNOCORE HOLDINGS PLC-ADR | IMCR | 0.06% |
 INNOVIVA INC | INVA | 0.05% |
 HARROW INC | HROW | 0.05% |
 VIR BIOTECHNOLOGY INC | VIR | 0.05% |
 PERSONALIS INC | PSNL | 0.05% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.05% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.05% |
 ABSCI CORP | ABSI | 0.05% |
 XERIS BIOPHARMA HOLDINGS INC | XERS | 0.05% |
 MONTE ROSA THERAPEUTICS INC | GLUE | 0.05% |
 NOVAVAX INC | NVAX | 0.05% |
 INHIBRX BIOSCIENCES INC | INBX | 0.05% |
 VOR BIOPHARMA INC | VOR | 0.05% |
 MANNKIND CORP | MNKD | 0.05% |
 ETON PHARMACEUTICALS INC | ETON | 0.04% |
 MEIRAGTX HOLDINGS PLC | MGTX | 0.04% |
 SAVARA INC | SVRA | 0.04% |
 ALVOTECH SA | ALVO | 0.04% |
 WAVE LIFE SCIENCES LTD | WVE | 0.04% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.04% |
 EYEPOINT INC | EYPT | 0.04% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.04% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.04% |
 REPLIMUNE GROUP INC | REPL | 0.04% |
 ARDELYX INC | ARDX | 0.04% |
 PACIRA BIOSCIENCES INC | PCRX | 0.04% |
 SANA BIOTECHNOLOGY INC | SANA | 0.04% |
 CASTLE BIOSCIENCES INC | CSTL | 0.04% |
 GRIFOLS SA-ADR | GRFS | 0.04% |
 JANUX THERAPEUTICS INC | JANX | 0.04% |
 OMEROS CORP | OMER | 0.03% |
 COLLEGIUM PHARMACEUTICAL INC | COLL | 0.03% |
 GERON CORP | GERN | 0.03% |
 MARAVAI LIFESCIENCES HLDGS-A | MRVI | 0.03% |
 AMPHASTAR PHARMACEUTICALS IN | AMPH | 0.03% |
 ARBUTUS BIOPHARMA CORP | ABUS | 0.03% |
 ANNEXON INC | ANNX | 0.03% |
 DESIGN THERAPEUTICS INC | DSGN | 0.03% |
 THERAVANCE BIOPHARMA INC | TBPH | 0.03% |
 KURA ONCOLOGY INC | KURA | 0.03% |
 MESOBLAST LTD- SPON ADR | MESO | 0.03% |
 AURA BIOSCIENCES INC | AURA | 0.03% |
 SOLID BIOSCIENCES INC | SLDB | 0.03% |
 ACLARIS THERAPEUTICS INC | ACRS | 0.03% |
 CANDEL THERAPEUTICS INC | CADL | 0.03% |
 ZAI LAB LTD-ADR | ZLAB | 0.03% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.03% |
 RIGEL PHARMACEUTICALS INC | RIGL | 0.03% |
 PHIBRO ANIMAL HEALTH CORP-A | PAHC | 0.03% |
 IRONWOOD PHARMACEUTICALS INC | IRWD | 0.03% |
 ALLOGENE THERAPEUTICS INC | ALLO | 0.03% |
 ZEVRA THERAPEUTICS INC | ZVRA | 0.02% |
 PHATHOM PHARMACEUTICALS INC | PHAT | 0.02% |
 ARS PHARMACEUTICALS INC | SPRY | 0.02% |
 ALTIMMUNE INC | ALT | 0.02% |
 TECTONIC THERAPEUTIC INC | TECX | 0.02% |
 CORMEDIX INC | CRMD | 0.02% |
 NEUROGENE INC | NGNE | 0.02% |
 ARVINAS INC | ARVN | 0.02% |
 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.02% |
 SILENCE THERAPEUTICS PLC-ADR | SLN | 0.02% |
 PRIME MEDICINE INC | PRME | 0.02% |
 REGENXBIO INC | RGNX | 0.02% |
 SAGIMET BIOSCIENCES INC-A | SGMT | 0.02% |
 BIOAGE LABS INC | BIOA | 0.02% |
 EVOLUS INC | EOLS | 0.02% |
 AQUESTIVE THERAPEUTICS INC | AQST | 0.02% |
 CONTINEUM THERAPEUTICS INC-A | CTNM | 0.02% |
 KYVERNA THERAPEUTICS INC | KYTX | 0.02% |
 PROTHENA CORP PLC | PRTA | 0.02% |
 CABALETTA BIO INC | CABA | 0.02% |
 PUMA BIOTECHNOLOGY INC | PBYI | 0.02% |
 OMNIAB INC | OABI | 0.02% |
 EDITAS MEDICINE INC | EDIT | 0.02% |
 LARIMAR THERAPEUTICS INC | LRMR | 0.02% |
 AUTOLUS THERAPEUTICS PLC | AUTL | 0.02% |
 ATEA PHARMACEUTICALS INC | AVIR | 0.02% |
 KAMADA LTD | KMDA | 0.02% |
 C4 THERAPEUTICS INC | CCCC | 0.01% |
 LAKEFRONT BIOTHERAPEUTIC-ADR | LKFT | 0.01% |
 ENANTA PHARMACEUTICALS INC | ENTA | 0.01% |
 UPSTREAM BIO INC | UPB | 0.01% |
 ROCKET PHARMACEUTICALS INC | RCKT | 0.01% |
 LEXEO THERAPEUTICS INC | LXEO | 0.01% |
 PACIFIC BIOSCIENCES OF CALIF | PACB | 0.01% |
 FOGHORN THERAPEUTICS INC | FHTX | 0.01% |
 ALPHA TEKNOVA INC | TKNO | 0.01% |
 LYELL IMMUNOPHARMA INC | LYEL | 0.01% |
 ANAVEX LIFE SCIENCES CORP | AVXL | 0.01% |
 NEUMORA THERAPEUTICS INC | NMRA | 0.01% |
 VANDA PHARMACEUTICALS INC | VNDA | 0.01% |
 IMMUNEERING CORP - CLASS A | IMRX | 0.01% |
 ENTRADA THERAPEUTICS INC | TRDA | 0.01% |
 FULCRUM THERAPEUTICS INC | FULC | 0.01% |
 ORCHESTRA BIOMED HOLDINGS IN | OBIO | 0.01% |
 AC IMMUNE SA | ACIU | 0.01% |
 PYXIS ONCOLOGY INC | PYXS | 0.01% |
 KEROS THERAPEUTICS INC | KROS | 0.01% |
 SIGA TECHNOLOGIES INC | SIGA | 0.01% |
 INVIVYD INC | IVVD | 0.01% |
 ARCTURUS THERAPEUTICS HOLDIN | ARCT | 0.01% |
 VOYAGER THERAPEUTICS INC | VYGR | 0.01% |
 PEPGEN INC | PEPG | 0.01% |
 NOVABRIDGE BIOSCIENCES | NBP | 0.01% |
 COHERUS ONCOLOGY INC | CHRS | 0.01% |
 BICYCLE THERAPEUTICS PLC-ADR | BCYC | 0.01% |
 LIFECORE BIOMEDICAL INC | LFCR | 0.01% |
 AARDVARK THERAPEUTICS INC | AARD | 0.01% |
 LENZ THERAPEUTICS INC | LENZ | 0.01% |
 CARIBOU BIOSCIENCES INC | CRBU | 0.01% |
 QUANTUM-SI INC | QSI | 0.01% |
 HUMACYTE INC | HUMA | 0.01% |
 TENAYA THERAPEUTICS INC | TNYA | 0.01% |
 JYONG BIOTECH LTD | MENS | 0.01% |
 CODEXIS INC | CDXS | 0% |
 BLACK DIAMOND THERAPEUTICS I | BDTX | 0% |
 RANI THERAPEUTICS HOLDINGS-A | RANI | 0% |
 GOSSAMER BIO INC | GOSS | 0% |
 THIRD HARMONIC BIO INC | THRD | 0% |
 NASDAQ Biotechnology Index SWAP Citibank NA | NASDAQ.Biotechnology.Index.SWAP.Citibank.NA | 0% |
 NASDAQ Biotechnology Index SWAP Bank of America NA | NASDAQ.Biotechnology.Index.SWAP.Bank.of.America.NA | 0% |
 NASDAQ Biotechnology Index SWAP UBS AG | NASDAQ.Biotechnology.Index.SWAP.UBS.AG | 0% |
 CARTESIAN THERAPEUTICS-CVR | CARTESIAN.THERAPEUTICS.CVR | 0% |
 NASDAQ Bio Index SWAP BNP Paribas | NASDAQ.Bio.Index.SWAP.BNP.Paribas | 0% |
 NASDAQ Biotechnology Index SWAP Goldman Sachs International | NASDAQ.Biotechnology.Index.SWAP.Goldman.Sachs.International | 0% |
 NASDAQ Biotechnology Index SWAP Societe Generale | NASDAQ.Biotechnology.Index.SWAP.Societe.Generale | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
ProShares Ultra Nasdaq Biotechnology (BIB) share price today is $106.438.
Yes, Indians can buy shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. To buy BIB from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. You can start investing in ProShares Ultra Nasdaq Biotechnology (BIB) with a minimum investment of $1.
The 52-week high price of ProShares Ultra Nasdaq Biotechnology (BIB) is $110.25. The 52-week low price of ProShares Ultra Nasdaq Biotechnology (BIB) is $50.05.
The stock symbol (or ticker) of ProShares Ultra Nasdaq Biotechnology is BIB.
Yes, you can setup SIP in ProShares Ultra Nasdaq Biotechnology shares. Follow the below steps to create the SIP:
Here is the historical performance of BIB on the Vested app.
The expense ratio of ProShares Ultra Nasdaq Biotechnology (BIB) is 0.95%.
Link copied 
